Literature DB >> 30406698

Zinc ameliorates intestinal barrier dysfunctions in shigellosis by reinstating claudin-2 and -4 on the membranes.

Paramita Sarkar1, Tultul Saha1, Irshad Ali Sheikh1, Subhra Chakraborty2, Joydeep Aoun1, Manoj Kumar Chakrabarti1, Vazhaikkurichi M Rajendran3, Nadia A Ameen4, Shanta Dutta5, Kazi Mirajul Hoque1,6.   

Abstract

Whether zinc (Zn2+) regulates barrier functions by modulating tight-junction (TJ) proteins when pathogens such as Shigella alter epithelial permeability is still unresolved. We investigated the potential benefits of Zn2+ in restoring impaired barrier function in vivo in Shigella-infected mouse tissue and in vitro in T84 cell monolayers. Basolateral Shigella infection triggered a time-dependent decrease in transepithelial resistance followed by an increase in paracellular permeability of FITC-labeled dextran and altered ion selectivity. This led to ion and water loss into the intestinal lumen. Immunofluorescence studies revealed redistribution of claudin-2 and -4 to an intracellular location and accumulation of these proteins in the cytoplasm following infection. Zn2+ ameliorated this perturbed barrier by redistribution of claudin-2 and -4 back to the plasma membrane and by modulating the phosphorylation state of TJ proteins t hough extracellular signal-regulated kinase (ERK)1/2 dependency. Zn2+ prevents elevation of IL-6 and IL-8. Mice challenged with Shigella showed that oral Zn2+supplementation diminished diverse pathophysiological symptoms of shigellosis. Claudin-2 and -4 were susceptible to Shigella infection, resulting in altered barrier function and increased levels of IL-6 and IL-8. Zn2+ supplementation ameliorated this barrier dysfunction, and the inflammatory response involving ERK-mediated change of phosphorylation status for claudin-2 and -4. Thus, Zn2+ may have potential therapeutic value in inflammatory diarrhea and shigellosis. NEW & NOTEWORTHY Our study addresses whether Zn2+ could be an alternative strategy to reduce Shigella-induced inflammatory response and epithelial barrier dysfunction. We have defined a mechanism in terms of intracellular signaling pathways and tight-junction protein expression by Zn2+. Claudin-2 and -4 are susceptible to Shigella infection, whereas in the presence of Zn2+ they are resistant to infection-related barrier dysfunction involving ERK-mediated change of phosphorylation status of claudins.

Entities:  

Keywords:  intestinal inflammation; claudin; diarrhea; tight junction

Mesh:

Substances:

Year:  2018        PMID: 30406698      PMCID: PMC6397338          DOI: 10.1152/ajpgi.00092.2018

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  46 in total

1.  Paracellular Cl- permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension.

Authors:  Kristopher T Kahle; Gordon G Macgregor; Frederick H Wilson; Alfred N Van Hoek; Dennis Brown; Thomas Ardito; Michael Kashgarian; Gerhard Giebisch; Steven C Hebert; Emile L Boulpaep; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

Review 2.  Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?

Authors:  Armelle Phalipon; Philippe J Sansonetti
Journal:  Immunol Cell Biol       Date:  2007-01-09       Impact factor: 5.126

3.  A new insight into pathophysiological mechanisms of zinc in diarrhea.

Authors:  Kazi Mirajul Hoque; Rafiquel Sarker; Sandra E Guggino; Chung-Ming Tse
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

4.  Use of polyethylene glycol and phenol red as unabsorbed indicators for intestinal absorption studies in man.

Authors:  H P Schedl
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

5.  MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide.

Authors:  Shyamali Basuroy; Ankur Seth; Bertha Elias; Anjaparavanda P Naren; Radhakrishna Rao
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

6.  Claudin-2, a component of the tight junction, forms a paracellular water channel.

Authors:  Rita Rosenthal; Susanne Milatz; Susanne M Krug; Beibei Oelrich; Jörg-Dieter Schulzke; Salah Amasheh; Dorothee Günzel; Michael Fromm
Journal:  J Cell Sci       Date:  2010-05-11       Impact factor: 5.285

7.  Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers.

Authors:  Sudhir Aggarwal; Takuya Suzuki; William L Taylor; Aditi Bhargava; Radhakrishna K Rao
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

8.  ERK is involved in EGF-mediated protection of tight junctions, but not adherens junctions, in acetaldehyde-treated Caco-2 cell monolayers.

Authors:  G Samak; S Aggarwal; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-07       Impact factor: 4.052

9.  Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.

Authors:  T K Sengupta; E M Schmitt; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells.

Authors:  Takanori Sakaguchi; Henrik Köhler; Xiubin Gu; Beth A McCormick; Hans-Christian Reinecker
Journal:  Cell Microbiol       Date:  2002-06       Impact factor: 3.715

View more
  8 in total

Review 1.  Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis.

Authors:  Nan Yao; Yixue Yang; Xiaotong Li; Yuxiang Wang; Ruirui Guo; Xuhan Wang; Jing Li; Zechun Xie; Bo Li; Weiwei Cui
Journal:  Front Nutr       Date:  2022-06-17

2.  A Dual Zinc plus Arginine formulation attenuates the pathogenic properties of Porphyromonas gingivalis and protects gingival keratinocyte barrier function in an in vitro model.

Authors:  Amel Ben Lagha; Ying Yang; Harsh M Trivedi; James G Masters; Daniel Grenier
Journal:  J Oral Microbiol       Date:  2020-08-04       Impact factor: 5.474

Review 3.  Gut Microbiota as a Mediator of Essential and Toxic Effects of Zinc in the Intestines and Other Tissues.

Authors:  Anatoly V Skalny; Michael Aschner; Xin Gen Lei; Viktor A Gritsenko; Abel Santamaria; Svetlana I Alekseenko; Nagaraja Tejo Prakash; Jung-Su Chang; Elena A Sizova; Jane C J Chao; Jan Aaseth; Alexey A Tinkov
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

4.  The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.

Authors:  Kazi Mirajul Hoque; Eryn E Dixon; Raychel M Lewis; Jordyn Allan; Gregory D Gamble; Amanda J Phipps-Green; Victoria L Halperin Kuhns; Anne M Horne; Lisa K Stamp; Tony R Merriman; Nicola Dalbeth; Owen M Woodward
Journal:  Nat Commun       Date:  2020-06-02       Impact factor: 14.919

5.  The Znt7-null mutation has sex dependent effects on the gut microbiota and goblet cell population in the mouse colon.

Authors:  Mary E Kable; Niknaz Riazati; Catherine P Kirschke; Junli Zhao; Surapun Tepaamorndech; Liping Huang
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

6.  Role of Nuclear Claudin-4 in Renal Cell Carcinoma.

Authors:  Takuya Owari; Takamitsu Sasaki; Kiyomu Fujii; Rina Fujiwara-Tani; Shingo Kishi; Shiori Mori; Takuya Mori; Kei Goto; Isao Kawahara; Yasushi Nakai; Makito Miyake; Yi Luo; Nobumichi Tanaka; Masuo Kondoh; Kiyohide Fujimoto; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

7.  Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity.

Authors:  Yuki Fujimoto; Kosuke Kaji; Norihisa Nishimura; Masahide Enomoto; Koji Murata; Soichi Takeda; Hiroaki Takaya; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Hitoshi Yoshiji
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

Review 8.  Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy.

Authors:  Katherine M DiGuilio; Elizabeth Rybakovsky; Reza Abdavies; Romy Chamoun; Colleen A Flounders; Ariel Shepley-McTaggart; Ronald N Harty; James M Mullin
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.